Paying it forward: The trailblazing Cambridge entrepreneurs engineering the next wave of global innovators

7 Nov

Written By Alexandra Collingbourne

Alexandra Collingbourne

T-Therapeutics announces Series A extension to $91 million to advance first-in-class bispecifics towards the clinic

Cambridge Angels CEO has earned her wings and then some!